litlas
Log inCreate account

Mark A. Magnuson

Active 1975–2025

Also published as
Mark A Magnuson
146
Papers
30,905
Citations
108
h-index
145
i10-index

Citations

Citations per year for Mark A. Magnuson1978: 2 citations1979: 1 citations1982: 1 citations1985: 1 citations1986: 6 citations1987: 1 citations1988: 16 citations1989: 19 citations1990: 45 citations1991: 51 citations1992: 46 citations1993: 68 citations1994: 74 citations1995: 55 citations1996: 56 citations1997: 79 citations1998: 85 citations1999: 114 citations2000: 186 citations2001: 230 citations2002: 277 citations2003: 263 citations2004: 359 citations2005: 355 citations2006: 415 citations2007: 362 citations2008: 427 citations2009: 416 citations2010: 374 citations2011: 351 citations2012: 380 citations2013: 403 citations2014: 365 citations2015: 333 citations2016: 304 citations2017: 295 citations2018: 247 citations2019: 752 citations2020: 701 citations2021: 778 citations2022: 538 citations2023: 372 citations2024: 448 citations2025: 225 citations1980–1981: no citations, so these years are not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,756 citing papers, 37.6% of this breakdownChina: 941 citing papers, 7.4% of this breakdownUnited Kingdom: 799 citing papers, 6.3% of this breakdownGermany: 674 citing papers, 5.3% of this breakdownJapan: 594 citing papers, 4.7% of this breakdownFrance: 518 citing papers, 4.1% of this breakdownCanada: 466 citing papers, 3.7% of this breakdownSwitzerland: 344 citing papers, 2.7% of this breakdownItaly: 339 citing papers, 2.7% of this breakdownSpain: 308 citing papers, 2.5% of this breakdownSweden: 269 citing papers, 2.1% of this breakdownAustralia: 243 citing papers, 1.9% of this breakdown
0%37.6%Other 19%

Institutions

Fields

  • Medicine53.4%
  • Biochemistry, Genetics and Molecular Biology35.4%
  • Neuroscience4.8%
  • Immunology and Microbiology3%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Agricultural and Biological Sciences0.7%
  • Other1.9%

Topics

  • Pancreatic function and diabetes10.7%
  • Metabolism, Diabetes, and Cancer4.8%
  • Diabetes and associated disorders3.6%
  • Adipose Tissue and Metabolism2.7%
  • PI3K/AKT/mTOR signaling in cancer2.4%
  • Liver Disease Diagnosis and Treatment2%
  • Other73.8%

Coauthors

All papers

Open in search
  1. Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase

    Authors: Catherine Postic, Masakazu Shiota, Kevin D. Niswender, Thomas L. Jetton, Yeujin Chen, J. Michael Moates, Kathy D. Shelton, J Lindner, Alan D. Cherrington, Mark A. Magnuson - Journal of Biological Chemistry 1999 cited by 1,338

  2. p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion

    Authors: Aharon Helman, Agnes Klochendler, Narmen Azazmeh, Yael Gabai, E. Philip Horwitz, Shira Anzi, Avital Swisa, Reba Condiotti, Roy Z. Granit, Yuval Nevo, Yaakov Fixler, Dorin Shreibman, Amit Zamir, Sharona Tornovsky-Babeay, Chunhua Dai, Benjamin Gläser, Alvin C. Powers, A. M. James Shapiro, Mark A. Magnuson, Yuval Dor, Ittai Ben‐Porath - Nature Medicine 2016 cited by 354

  3. Loss of Insulin Signaling in Hepatocytes Leads to Severe Insulin Resistance and Progressive Hepatic Dysfunction

    Authors: M.Dodson Michael, Rohit Kulkarni, Catherine Postic, Steven F. Previs, Gerald I. Shulman, Mark A. Magnuson, C. Ronald Kahn - Molecular Cell 2000 cited by 1,249

  4. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver

    Authors: Santhosh Satapati, Blanka Kucejová, João Duarte, Justin A. Fletcher, Lacy Reynolds, Nishanth E. Sunny, TianTeng He, Lawrence Nair, Kenneth Livingston, Xiaorong Fu, Matthew E. Merritt, A. Dean Sherry, Craig R. Malloy, John M. Shelton, Jennifer E. Lambert, Elizabeth J. Parks, Ian R. Corbin, Mark A. Magnuson, Jeffrey D. Browning, Shawn C. Burgess - Journal of Clinical Investigation 2015 cited by 402

  5. Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes

    Authors: Rohit Kulkarni, Jens C. Brüning, Jonathon N. Winnay, Catherine Postic, Mark A. Magnuson, C.Ronald Kahn - Cell 1999 cited by 1,153

  6. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity

    Authors: Bangyan L. Stiles, Ying Wang, Andreas Stahl, Sara Bassilian, W. Paul Lee, Yun Joong Kim, Robert Sherwin, Sherin U. Devaskar, Ralf Lesche, Mark A. Magnuson, Hong Wu - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 435

  7. Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling Pathways

    Authors: Keunwook Lee, Prathyusha Gudapati, Srdjan M. Dragovic, Charles T. Spencer, Sebastian Joyce, Nigel Killeen, Mark A. Magnuson, Mark Boothby - Immunity 2010 cited by 462

  8. Identification of Protor as a novel Rictor-binding component of mTOR complex-2

    Authors: Laura R. Pearce, Xu Huang, Jérôme Boudeau, Rafał Pawłowski, Stephan Wullschleger, Mária Deák, Adel F.M. Ibrahim, Robert Gourlay, Mark A. Magnuson, Dario R. Alessi - Biochemical Journal 2007 cited by 450

  9. Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance

    Authors: Julie R. Jones, Cordelia J. Barrick, Kyoung‐Ah Kim, J Lindner, B. Blondeau, Yuka Fujimoto, Masakazu Shiota, Robert A. Kesterson, Barbara B. Kahn, Mark A. Magnuson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 479

  10. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum

    Authors: Martin F. Offield, Tom L. Jetton, Patricia A. Labosky, Michael Ray, Roland Stein, Mark A. Magnuson, Brigid L.M. Hogan, Christopher V.E. Wright - Development 1996 cited by 1,525

  11. Cytosolic Phosphoenolpyruvate Carboxykinase Does Not Solely Control the Rate of Hepatic Gluconeogenesis in the Intact Mouse Liver

    Authors: Shawn C. Burgess, Tian-Teng He, Zheng Yan, J Lindner, A. Dean Sherry, Craig R. Malloy, Jeffrey D. Browning, Mark A. Magnuson - Cell Metabolism 2007 cited by 277

  12. Impaired insulin secretion and glucose tolerance in β cell‐selective CaV1.2 Ca2+ channel null mice

    Authors: Verena Schulla, Erik Renström, Robert Feil, Susanne Feil, Isobel Franklin, Asllan Gjinovci, Xingjun Jing, Dirk Laux, Ingmar Lundquist, Mark A. Magnuson, Stefanie Obermüller, Charlotta S. Olofsson, Albert Salehi, Anna Wendt, Norbert Klugbauer, Claes B. Wollheim, Patrik Rorsman, Franz Hofmann - The EMBO Journal 2003 cited by 236

  13. Pancreas-Specific Cre Driver Lines and Considerations for Their Prudent Use

    Authors: Mark A. Magnuson, Anna B. Osipovich - Cell Metabolism 2013 cited by 188

  14. Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene Expression

    Authors: Renaud Dentin, Jean‐Paul Pégorier, Fadila Benhamed, Fabienne Foufelle, Pascal Ferré, Véronique Fauveau, Mark A. Magnuson, Jean Girard, Catherine Postic - Journal of Biological Chemistry 2004 cited by 433

  15. Impaired insulin secretion and β-cell loss in tissue-specific knockout mice with mitochondrial diabetes

    Authors: José Silva, Martin Köhler, Caroline Graff, Anders Oldfors, Mark A. Magnuson, Per‐Olof Berggren, Nils‐Göran Larsson - Nature Genetics 2000 cited by 437

  16. Neonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency

    Authors: Pål R. Njølstad, Oddmund Sövik, Antonio L. Cuesta‐Muñoz, Lise Bjørkhaug, Ornella Massa, Fabrizio Barbetti, Dag E. Undlien, Chiyo Shiota, Mark A. Magnuson, Anders Molven, Franz M. Matschinsky, Graeme I. Bell - New England Journal of Medicine 2001 cited by 428

  17. Control of Pancreatic β Cell Regeneration by Glucose Metabolism

    Authors: Shay Porat, Noa Weinberg-Corem, Sharona Tornovsky-Babaey, Rachel Ben‐Haroush Schyr, Ayat Hija, Miri Stolovich-Rain, Daniela Dadon, Zvi Granot, Vered Ben-Hur, Peter White, Christophe A. Girard, Rotem Karni, Klaus H. Kaestner, Frances M. Ashcroft, Mark A. Magnuson, Ann Saada, Joseph Grimsby, Benjamin Gläser, Yuval Dor - Cell Metabolism 2011 cited by 301

  18. Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration

    Authors: Fong Cheng Pan, Eric D. Bankaitis, Daniel F. Boyer, Xiaobo Xu, Mark Van de Casteele, Mark A. Magnuson, Harry Heimberg, Christopher V.E. Wright - Development 2013 cited by 294

  19. Conditional inactivation of the TGF‐β type II receptor using Cre:Lox

    Authors: Anna Chytil, Mark A. Magnuson, Christopher V.E. Wright, Harold L. Moses - genesis 2002 cited by 275

  20. p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network

    Authors: Clayton B. Marshall, Deborah J. Mays, J. Scott Beeler, Jennifer M. Rosenbluth, Kelli L. Boyd, Gabriela L. Santos Guasch, Timothy M. Shaver, Lucy J. Tang, Qi Liu, Yu Shyr, Bryan J. Venters, Mark A. Magnuson, Jennifer A. Pietenpol - Cell Reports 2016 cited by 144

  21. Temporal recording of mammalian development and precancer

    Authors: Mirazul Islam, Yilin Yang, Alan J. Simmons, Vishal M. Shah, Musale Krushna Pavan, Yanwen Xu, Naila Tasneem, Zhengyi Chen, Linh T. Trinh, Paola Molina, Marisol Ramirez‐Solano, Iannish Sadien, Jinzhuang Dou, Andrea Rolong, Ken Chen, Mark A. Magnuson, Jeffrey C. Rathmell, Ian G. Macara, Douglas J. Winton, Qi Liu, Hamim Zafar, Reza Kalhor, George M. Church, Martha J. Shrubsole, Robert J. Coffey, Ken S. Lau - Nature 2024 cited by 27

  22. Allosteric Activators of Glucokinase: Potential Role in Diabetes Therapy

    Authors: Joseph Grimsby, Ramakanth Sarabu, Wendy L. Corbett, Nancy-Ellen Haynes, Fred T. Bizzarro, John W. Coffey, Kevin R. Guertin, Darryl W. Hilliard, Robert F. Kester, Paige E. Mahaney, Linda Marcus, Lida Qi, Cheryl Spence, J. P. TENGI, Mark A. Magnuson, Chang An Chu, Mark Dvorozniak, Franz M. Matschinsky, Joseph F. Grippo - Science 2003 cited by 537

  23. mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice

    Authors: David A. Guertin, Deanna M. Stevens, Maki Saitoh, Stephanie Kinkel, Katherine Crosby, Joon-Ho Sheen, David J. Mullholland, Mark A. Magnuson, Hong Wu, David M. Sabatini - Cancer Cell 2009 cited by 401

  24. The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy

    Authors: Franz M. Matschinsky, Mark A. Magnuson, Dorothy Zelent, Tom L. Jetton, Nicolai M. Doliba, Yi Han, Rebecca Taub, Joseph Grimsby - Diabetes 2006 cited by 297